<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An adult woman with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, <z:hpo ids='HP_0001528'>hemihypertrophy</z:hpo> and an <z:chebi fb="3" ids="50113">androgen</z:chebi>-secreting <z:mp ids='MP_0009044'>adrenal adenoma</z:mp> is described </plain></SENT>
<SENT sid="1" pm="."><plain>She presented with a 7-year history of progressive virilization and was found to have high plasma levels of <z:chebi fb="51" ids="17347">testosterone</z:chebi> and dehydroepiandrosterone (DHEA) <z:chebi fb="100" ids="16189">sulphate</z:chebi> and elevated levels of urinary metabolites of <z:chebi fb="51" ids="17347">testosterone</z:chebi> and its precursors </plain></SENT>
<SENT sid="2" pm="."><plain>Administration of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> was associated with progressive rises in plasma 17 alpha OH <z:chebi fb="28" ids="17026">progesterone</z:chebi>, 11 beta-desoxycortisol, DHEA <z:chebi fb="100" ids="16189">sulphate</z:chebi>, androstenedione and <z:chebi fb="51" ids="17347">testosterone</z:chebi>, together with increased urinary excretion of <z:chebi fb="1" ids="16032">androsterone</z:chebi>, 11 beta OH <z:chebi fb="1" ids="16032">androsterone</z:chebi>, <z:chebi fb="0" ids="28195">etiocholanolone</z:chebi>, DHEA, and 16 alpha OH DHEA </plain></SENT>
<SENT sid="3" pm="."><plain>Hormone levels fell to <z:mpath ids='MPATH_458'>normal</z:mpath> following removal of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
</text></document>